Temporal Association of Bleeding to Survival
| . | Outcome by Intervals From the Last Day of BLD Episode . | ||
|---|---|---|---|
| Death Within 0-5 d . | Death Within 6-30 d . | Alive >30 d . | |
| A. Autologous BMT | |||
| Minor BLD | 5 (4.8%) | 4 (3.8%) | 95 (91.4%) |
| Moderate BLD | 15 (17.4%) | 6 (7%) | 65 (75.6%) |
| Severe BLD | 34 (45.3%) | 2 (2.7%) | 39 (52%) |
| B. Allogeneic BMT | |||
| Minor BLD | 5 (11.9%) | 2 (4.8%) | 35 (83.3%) |
| Moderate BLD | 29 (47.5%) | 5 (8.2%) | 27 (44.3%) |
| Severe BLD | 61 (79.2%) | 4 (5.2%) | 12 (15.6%) |
| . | Outcome by Intervals From the Last Day of BLD Episode . | ||
|---|---|---|---|
| Death Within 0-5 d . | Death Within 6-30 d . | Alive >30 d . | |
| A. Autologous BMT | |||
| Minor BLD | 5 (4.8%) | 4 (3.8%) | 95 (91.4%) |
| Moderate BLD | 15 (17.4%) | 6 (7%) | 65 (75.6%) |
| Severe BLD | 34 (45.3%) | 2 (2.7%) | 39 (52%) |
| B. Allogeneic BMT | |||
| Minor BLD | 5 (11.9%) | 2 (4.8%) | 35 (83.3%) |
| Moderate BLD | 29 (47.5%) | 5 (8.2%) | 27 (44.3%) |
| Severe BLD | 61 (79.2%) | 4 (5.2%) | 12 (15.6%) |
The intervals between the last day of bleeding to outcome estimates (death within 30 days or any outcome longer than 30 days) showed that, the more severe the overall bleeding episode was, the stronger was the timing association to death, as analyzed for 275 autologous and 180 allogeneic patients.